Figure 1.
The Consolidated Standards of Reporting Trial Flow Diagram. A total of 1773 patients were identified in the institutional database who had undergone cardiac surgery during the era studied. After exclusion of subjects per specified criteria 1610 patients remained. Analysis was completed on 824 patients receiving TXA, whereas 778 received EACA (8 patients removed from analysis due to death in the operating room). TXA, Tranexamic acid; EACA, epsilon-aminocaproic acid.